Basic Principles of Purine Degradation
Purine nucleotide catabolism is a multi-step process that can be broadly divided into three types of biochemical reactions:
- Hydrolysis — removal of inorganic phosphate from the starting nucleotide.
- Deamination — removal of an amino group with the release of free ammonia.
- Oxidation — incorporation of oxygen into the molecule.
Interestingly, the salvage and degradation pathways of adenylic (AMP) and guanylic (GMP) nucleotides begin differently, but eventually converge at a single point: the formation of xanthine.
AMP Degradation Pathway
The breakdown of adenylic nucleotides involves several consecutive steps leading to the formation of hypoxanthine:
- First, a phosphate group is hydrolytically cleaved from AMP. This dephosphorylation reaction is catalyzed by nucleotidase (5'-nucleotidase), resulting in the nucleoside adenosine.
- Next, adenosine deaminase (ADA) acts on adenosine, removing an ammonia molecule via deamination to yield inosine.
- In the third step, the N-glycosidic bond is cleaved. Purine nucleoside phosphorylase (PNP) performs phosphorolytic cleavage of inosine in the presence of inorganic phosphate. Ribose is removed as ribose-1-phosphate, leaving behind the free nitrogenous base hypoxanthine.
GMP Degradation Pathway
Guanylic nucleotide catabolism is largely analogous to AMP breakdown, but features a different order of reactions and specific enzymes:
- As with AMP, the process begins with nucleotidase, which hydrolytically removes inorganic phosphate from GMP, converting it into guanosine.
- Next, purine nucleoside phosphorylase (PNP) removes the carbohydrate component (ribose as ribose-1-phosphate), releasing the free nitrogenous base guanine.
- In the final step of this branch, guanase deaminates guanine into xanthine, the convergence molecule where both degradation pathways meet.
Common Oxidation Phase
Once hypoxanthine (from AMP) and xanthine (from GMP) are formed, the oxidation phase begins. The primary actor here is xanthine oxidase, an oxidoreductase enzyme.
This enzyme sequentially catalyzes two reactions:
- Oxidation of hypoxanthine to xanthine.
- Oxidation of xanthine to uric acid (involving the introduction of a hydroxyl group at the C8 position of the purine ring).
Both reactions require molecular oxygen and water. A secondary but vital product of these oxidative processes is hydrogen peroxide.
Enzymopathies and Immunodeficiencies
Genetic defects in enzymes involved in purine degradation lead to severe immune system pathologies:
- Adenosine Deaminase (ADA) Deficiency: Causes Severe Combined Immunodeficiency (SCID). Both T-lymphocytes and B-lymphocytes are severely affected. The mechanism involves the accumulation of deoxyadenosine, which is converted to dATP. Excess dATP inhibits ribonucleotide reductase, completely blocking DNA synthesis and leading to massive lymphocyte apoptosis.
- Purine Nucleoside Phosphorylase (PNP) Deficiency: Manifests as an immunodeficiency primarily affecting T-lymphocytes (B-cell function is often preserved). The underlying mechanism is the accumulation of dGTP, which exerts marked cellular toxicity on T-cells.